Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease
NCT06497387
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Lupus Nephritis
IgG4-related Disease
Interventions
BIOLOGICAL:
PRG-1801
Sponsor
Tongji Hospital
Collaborators
[object Object]